SCHEMBL28385448

SCHEMBL28385448

Fc1cnc(Nc2ccccc2)nc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 4/20 0.59
CDK2 P24941 3/20 0.59
IGF1R P08069 2/20 0.59
GSK3A P49840 2/20 0.59
GSK3B P49841 2/20 0.59
JAK2 O60674 2/20 0.59
CDK5 Q00535 2/20 0.59
PDPK1 O15530 2/20 0.59
CDK1 P06493 2/20 0.59
LYN P07948 2/20 0.59
FGFR1 P11362 2/20 0.59
FGFR3 P22607 2/20 0.59
RPS6KB1 P23443 2/20 0.59
MARK3 P27448 2/20 0.59
BLK P51451 2/20 0.59
RPS6KA3 P51812 2/20 0.59
ERBB4 Q15303 2/20 0.59
MARK2 Q7KZI7 2/20 0.59
PLK3 Q9H4B4 2/20 0.59
PLK4 O00444 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26022274 0.79 HDAC3 (0.51) AURKAKDRSYKSTK17AHDAC6
SCHEMBL3596154 0.79 KCNH2 (0.51) AURKACDK2IGF1RGSK3AGSK3B
SCHEMBL2492555 0.78 CDK2 (0.55) AURKACDK2IGF1RGSK3AGSK3B
SCHEMBL10974762 0.78 CHEK1 (0.60) AURKACDK2IGF1RGSK3AGSK3B
SCHEMBL18542558 0.78 HDAC6 (0.53) AURKACDK2IGF1RGSK3AGSK3B
SCHEMBL18434184 0.78 MAPT (0.55) AURKACDK2IGF1RGSK3AGSK3B
SCHEMBL3592120 0.78 IGF1R (0.59) AURKACDK2IGF1RGSK3AGSK3B
SCHEMBL18294906 0.78 HDAC6 (0.53) AURKACDK2IGF1RGSK3AGSK3B
SCHEMBL3587633 0.78 HDAC6 (0.58) AURKACDK2IGF1RGSK3AGSK3B
SCHEMBL3419180 0.78 IDH2 (0.57) AURKACDK2IGF1RGSK3AGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111072571-B Dithiocarbamates as FAK inhibitors 北京西博医药研究有限公司 2021-05-14 CN disclosed
CN-111072571-A Dithiocarbamates as FAK inhibitors 北京西博医药研究有限公司 2020-04-28 CN disclosed